| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Luis Alvarez-Vallina | Q55834901 |
| Marta Compte | Q59554011 | ||
| Laura Sanz | Q37830681 | ||
| P2093 | author name string | I Guijarro-Muñoz | |
| P2860 | cites work | Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect | Q24635138 |
| Progress and prospects: immune responses to viral vectors | Q28264531 | ||
| Hierarchical scaffold design for mesenchymal stem cell-based gene therapy of hemophilia B | Q28294014 | ||
| Mesenchymal stem cells within tumour stroma promote breast cancer metastasis | Q29614303 | ||
| Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 | Q29620590 | ||
| Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma | Q30885561 | ||
| Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model | Q33378960 | ||
| Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas | Q33382708 | ||
| Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies | Q33519052 | ||
| Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors | Q33560685 | ||
| Casting doubt on the safety of "off-the-shelf" mesenchymal stem cells for cell therapy | Q33713210 | ||
| Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients | Q33713301 | ||
| Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms | Q33713663 | ||
| Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases | Q33713800 | ||
| Intravenous mesenchymal stem cell therapy for traumatic brain injury | Q33929697 | ||
| Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model | Q34133208 | ||
| Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging | Q34164696 | ||
| Cell encapsulation: promise and progress | Q34168860 | ||
| Concise review: stem cells as an emerging platform for antibody therapy of cancer | Q34414838 | ||
| Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. | Q45857983 | ||
| A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice | Q45859123 | ||
| Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors | Q45869403 | ||
| Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells. | Q45870174 | ||
| Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model | Q45875290 | ||
| Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. | Q45882442 | ||
| Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy | Q47305010 | ||
| Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy. | Q47631011 | ||
| Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 | ||
| Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents | Q58828469 | ||
| Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model | Q79142180 | ||
| Distribution of circulation-derived endothelial progenitors following systemic delivery | Q79963887 | ||
| Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels | Q80638852 | ||
| Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells | Q80794400 | ||
| Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals | Q34575418 | ||
| Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? | Q34774078 | ||
| Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy | Q35000974 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| Immune responses to gene therapy vectors: influence on vector function and effector mechanisms | Q35904408 | ||
| Gene therapy: can neural stem cells deliver? | Q36350210 | ||
| Genetically engineered stem cells for therapeutic gene delivery | Q36985452 | ||
| Stem and progenitor cell-mediated tumor selective gene therapy | Q37120161 | ||
| Cell vehicle targeting strategies | Q37120169 | ||
| Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors | Q37120256 | ||
| Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy | Q37140126 | ||
| Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds. | Q37312523 | ||
| Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model | Q37398716 | ||
| Mesenchymal stem cell homing: the devil is in the details | Q37407769 | ||
| Biological gene delivery vehicles: beyond viral vectors | Q37412239 | ||
| Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapy. | Q37579760 | ||
| Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy | Q39245228 | ||
| Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model | Q39844128 | ||
| Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. | Q39852557 | ||
| Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma | Q39910399 | ||
| Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor | Q39945700 | ||
| Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats | Q39947440 | ||
| A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs | Q39999044 | ||
| Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells | Q40229749 | ||
| PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model | Q40382315 | ||
| Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy | Q41960388 | ||
| Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease | Q42092419 | ||
| Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice | Q42486323 | ||
| Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. | Q42804628 | ||
| Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells | Q42829407 | ||
| Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy | Q43100976 | ||
| Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy | Q43150773 | ||
| The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. | Q43599448 | ||
| Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. | Q44470878 | ||
| Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. | Q44538164 | ||
| Gene therapy of experimental brain tumors using neural progenitor cells | Q44761775 | ||
| Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation | Q44786842 | ||
| Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells | Q45180575 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-7 | |
| P577 | publication date | 2011-05-12 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Non-hematopoietic stem cells as factories for in vivo therapeutic protein production | |
| P478 | volume | 19 |
| Q99237969 | Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies |
| Q34231663 | Human mesenchymal stem cells resolve airway inflammation, hyperreactivity, and histopathology in a mouse model of occupational asthma |
| Q42560301 | In vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement. |
| Q43616044 | Nonviral gene delivery of erythropoietin by mesenchymal stromal cells |
| Q26741260 | Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumors |
| Q39098665 | Targeted therapy by gene transfer of a monovalent antibody fragment against the Met oncogenic receptor. |
| Q45876898 | Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model. |
Search more.